Skip to main contentSkip to navigation
Sirius Investors
Awakn Life Sciences Corp.

Awakn Life Sciences Corp.

AWKNF
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for AWKNF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
3.51M
-85.36% over period
CAGR: -47.30%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
3.11M
-86.93% over period
CAGR: -49.25%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Oct 31, 2023

EV/EBITDA

Distorted

-8.87x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-407.30K

EV is -11.6% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -10.6 pp vs earliest data

Additional Multiples

EV/Sales: 212.78x

Net Debt/EBITDA: 0.80x

Share count change in dataset: +130.17%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Jan 31, 20243.51M3.11M$0.1229.07M
Jan 31, 20238.54M10.28M$0.3425.20M
Jan 31, 202244.09M44.27M$2.0121.96M
Jan 31, 2021
————

Enterprise Value Analysis

Price Change (Jan 2023 to Jan 2024)

The stock price has decreased from Jan 2023 to Jan 2024.
-64.31%

Recent Volatility

The stock price has been relatively volatile over the last 4 periods, indicating a higher risk profile.
0.38

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-1.23

Market Cap Change (Jan 2023 to Jan 2024)

The company's market capitalization has decreased from Jan 2023 to Jan 2024.
-58.84%

Enterprise Value Change (Jan 2023 to Jan 2024)

The company's enterprise value has decreased from Jan 2023 to Jan 2024, suggesting a decline in the company's total economic value.
-69.78%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
-47.30%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
-49.25%